Women with elevated blood levels of two widely used "forever chemicals" experienced up to 93% higher rates of an aggressive form of breast cancer, according to a National Institutes of Health study that adds new weight to long-simmering concerns about the persistent compounds found in everything from nonstick cookware to food packaging and waterproof clothing.

The findings, which surfaced this week across science, general-interest and aggregator outlets, connect one of the most ubiquitous classes of industrial chemicals to a cancer subtype known for its fast progression and poorer outcomes — a link researchers say warrants urgent follow-up.

What the study found

The research examined women's exposure to per- and polyfluoroalkyl substances, or PFAS, and their subsequent rates of an aggressive breast cancer subtype. Women whose blood carried high concentrations of two of the most commonly detected PFAS compounds showed rates of the aggressive cancer up to 93% higher than those with lower exposure — approaching double the rate.

Women with high levels of two common "forever chemicals" had up to 93% higher rates of an aggressive form of breast cancer, the NIH study found — a discovery that raises concerns about the potential health effects of persistent chemicals found in everyday products.

Aggressive breast cancers — including triple-negative and certain HER2-positive tumors — are disproportionately difficult to treat because they grow and spread quickly and often lack the molecular targets that make other breast cancers responsive to hormone therapy. That biology makes any environmental risk factor for these subtypes a priority for public health researchers.

Why PFAS are so hard to avoid

PFAS are a family of thousands of synthetic fluorinated compounds manufactured since the 1940s for their ability to repel water, grease and heat. They are used in firefighting foam, stain-resistant fabrics, pizza boxes, cosmetics, dental floss and industrial processes. Their carbon-fluorine bonds are among the strongest in chemistry, which is why they resist degradation in the environment and accumulate in human blood — earning them the "forever chemical" label.

Because they migrate into drinking water, soil and food chains, exposure is effectively universal. Studies by the Centers for Disease Control and Prevention have detected PFAS in the blood of the vast majority of Americans tested. The compounds have been linked previously to kidney and testicular cancer, thyroid disease, immune suppression, and elevated cholesterol, and some have been associated with reduced vaccine response in children.

How different outlets framed the story

Coverage of the study diverged in emphasis in ways that illustrate how the same data point can travel through different editorial lenses.

  • Science-focused reporting led with the NIH provenance and the magnitude of the association — the 93% figure — framing the study as a signal about the health effects of persistent chemicals and situating it within the broader toxicology literature.
  • Fox News foregrounded consumer exposure, emphasizing that the chemicals are "found in everyday products" and presenting the finding as a dangerous cancer risk tied to routine household goods.
  • Aggregator headlines on MSN compressed the story to its most shareable form, pairing "forever chemicals" with "higher risk of aggressive breast cancer" and relying on the now-familiar cultural shorthand of the phrase itself.

The common thread across all four versions: a widely trusted institution (NIH), a well-known villain ("forever chemicals"), and a feared outcome (aggressive cancer). The differences were largely about how much context each outlet supplied about exposure routes, study design and what the findings do — and do not — prove.

The caveats scientists are urging

Observational studies of this kind establish association, not causation. Researchers typically measure blood PFAS concentrations at a single point in time, which may not reflect exposure during the critical windows when breast tissue is most vulnerable — particularly adolescence and pregnancy. Reverse causation, confounding by lifestyle or socioeconomic factors, and the possibility that underlying metabolic differences affect how the body retains PFAS all remain live questions.

The 93% figure, while striking, is a relative measure. Presenting relative risk without absolute risk — how many additional cases per 100,000 women — can inflate the apparent magnitude of an effect. Independent replication in a second cohort is the usual next step before findings influence clinical guidance, and researchers will likely want to examine whether a dose-response relationship holds across exposure levels.

The regulatory backdrop

The study arrives amid an accelerating regulatory backlash against PFAS. The Environmental Protection Agency finalized the first federal drinking-water limits for several PFAS compounds in 2024, and a growing list of states has restricted PFAS in firefighting foam, food packaging and consumer textiles. Internationally, some PFAS have been listed under the Stockholm Convention on Persistent Organic Pollutants. Industry groups have challenged parts of the regulatory push, arguing that the science on health effects is still developing and that sweeping restrictions could disrupt supply chains for semiconductors, medical devices and clean-energy technologies.

What it means for patients and consumers

For individual women, the practical message is not that a single product causes cancer but that cumulative, lifelong exposure matters — and that exposure reduction is a collective as well as personal responsibility. Oncologists and environmental health specialists generally advise that people concerned about PFAS prioritize drinking-water filtration certified to remove the compounds, reduce use of grease-resistant food packaging, and avoid unnecessary stain- and water-repellent treatments on household goods.

More importantly, researchers say, the burden of action should not fall solely on consumers. Because PFAS contamination is widespread and often involuntary, meaningful risk reduction requires regulation of industrial discharge, cleanup of contaminated sites and substitution of safer chemicals in manufacturing.

The NIH findings are unlikely to be the last word. But they add a compelling data point to a case that has been building for two decades — that the chemistry that made modern life convenient may carry a health cost that is only now coming into focus.